NCT05481983

Brief Summary

The research will be conducted with healthy pregnant women who applied to the Ege University Gynecology and Obstetrics Department Polyclinic, and were referred to the Sports Medicine Department.The study will consist of two groups as the control group and the exercise group.Voluntary pregnant women who are not found to be inconvenient to do moderate-intensity exercise by the doctor will participate in the study.The study was planned as a randomized controlled and single-blind study.The participant's demographic information, obstetric assessment, physical activity level, fall history and pain assessment will be recorded.Foot plantar pressure, static and dynamic balance, center of pressure (COP), subtalar joint evaluation and gait evaluation will be measured by pedobarography at Ege University Orthopedics and Traumatology Department Gait Laboratory.The control group will be offered walking as recommended by ACOG for pregnant women.Clinical exercise training will be given to pregnant women in the study group by a specialist physiotherapist.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
104

participants targeted

Target at P25-P50 for not_applicable pregnancy

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 3, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2023

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2023

Completed
Last Updated

February 28, 2023

Status Verified

February 1, 2023

Enrollment Period

10 months

First QC Date

May 3, 2022

Last Update Submit

February 27, 2023

Conditions

Keywords

pregnancyphysiotherapygait analysisclinical exerciseplantar pressure

Outcome Measures

Primary Outcomes (1)

  • Foot plantar pressure

    A change in gait pattern will be observed with pregnancy

    8 weeks

Study Arms (2)

control group

OTHER

Walk exercise

Other: Walk exercise

study group

ACTIVE COMPARATOR

One-on-one clinical exercise training

Other: One-on-one clinical exercise training

Interventions

The control group will be recommended to walk 5 days a week, 30-45 minutes (min.) (at least 150 minutes of physical activity per week), as recommended by ACOG for pregnant women. Exercise intensity will be given as 4-6 units for moderate-intensity exercise according to the Modified Perceived Difficulty Level (RPE).

control group

One-on-one clinical exercise training will be given by a specialist physiotherapist who has received special training in antenatal exercise. The program is designed to be 2 days a week for 8 weeks.

study group

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being between the ages of 18-40
  • No risk of pregnancy-related complications
  • Between 12th and 24th weeks of pregnancy

You may not qualify if:

  • History of lower extremity, pelvis or spine surgery
  • Pain in the lower extremity, pelvis, and spine that persists for more than 6 months
  • Any developmental delay related to the fetus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University Department of Sports Medicine

Izmir, Bornova, Turkey (Türkiye)

Location

Study Officials

  • SEÇKİN ŞENIŞIK, Doktor

    Ege University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The Randomization algorithm (Maximum Allowed % Deviation = 10%) was applied using PASS software 11.0 (NCSS LLC, Kaysville, UT) to generate a randomization list that would assign participants to two groups of 52 each.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomized control, single-blind
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist, MSc.

Study Record Dates

First Submitted

May 3, 2022

First Posted

August 1, 2022

Study Start

May 1, 2022

Primary Completion

February 27, 2023

Study Completion

December 28, 2023

Last Updated

February 28, 2023

Record last verified: 2023-02

Locations